13F HOLDINGS REPORT
Redmile Group, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-091352
Total Value
$2.61B
Positions
72
Other Managers
0
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IMMUNOGEN INC | 45253H101 | 17,730,417 | $334.6M | 12.84% |
| 2 | KRYSTAL BIOTECH INC | KRYS | 2,566,661 | $301.3M | 11.57% |
| 3 | AMICUS THERAPEUTICS INC | FOLD | 19,566,961 | $245.8M | 9.43% |
| 4 | REPLIMUNE GROUP INC | REPL | 4,420,533 | $102.6M | 3.94% |
| 5 | AKERO THERAPEUTICS INC | 00973Y108 | 1,811,672 | $84.6M | 3.25% |
| 6 | AUGMEDIX INC | 05105P107 | 15,630,327 | $75.2M | 2.89% |
| 7 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 4,878,566 | $68.7M | 2.64% |
| 8 | FATE THERAPEUTICS INC | FATE | 13,124,427 | $62.5M | 2.40% |
| 9 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,696,004 | $57.5M | 2.21% |
| 10 | LIVANOVA PLC | LIVN | 1,100,492 | $56.6M | 2.17% |
| 11 | CATALENT INC | 148806102 | 1,162,166 | $50.4M | 1.93% |
| 12 | ZYMEWORKS INC | ZYME | 5,661,230 | $48.9M | 1.88% |
| 13 | PLIANT THERAPEUTICS INC | PLRX | 2,678,099 | $48.5M | 1.86% |
| 14 | PENUMBRA INC | PEN | 138,970 | $47.8M | 1.84% |
| 15 | BEAM THERAPEUTICS INC | BEAM | 1,485,199 | $47.4M | 1.82% |
| 16 | XENON PHARMACEUTICALS INC | XENE | 1,120,476 | $43.1M | 1.66% |
| 17 | KYMERA THERAPEUTICS INC | KYMR | 1,868,507 | $43.0M | 1.65% |
| 18 | BIOMARIN PHARMACEUTICAL INC | BMRN | 489,208 | $42.4M | 1.63% |
| 19 | JAZZ PHARMACEUTICALS PLC | JAZZ | 341,882 | $42.4M | 1.63% |
| 20 | STOKE THERAPEUTICS INC | STOK | 3,955,188 | $42.0M | 1.61% |
| 21 | REGENXBIO INC | RGNX | 2,026,576 | $40.5M | 1.55% |
| 22 | DEXCOM INC | DXCM | 289,161 | $37.2M | 1.43% |
| 23 | IMMUNOVANT INC | IMVT | 1,921,152 | $36.4M | 1.40% |
| 24 | ELEVANCE HEALTH INC | ELV | 78,313 | $34.8M | 1.34% |
| 25 | SCHOLAR ROCK HLDG CORP | SRRK | 4,403,840 | $33.2M | 1.27% |
| 26 | VENTYX BIOSCIENCES INC | 92332V107 | 940,493 | $30.8M | 1.18% |
| 27 | ADC THERAPEUTICS SA | ADCT | 14,049,935 | $30.2M | 1.16% |
| 28 | NURIX THERAPEUTICS INC | NRIX | 2,857,309 | $28.5M | 1.10% |
| 29 | IGM BIOSCIENCES INC | 449585108 | 2,971,542 | $27.4M | 1.05% |
| 30 | STRYKER CORPORATION | SYK | 85,899 | $26.2M | 1.01% |
| 31 | REPARE THERAPEUTICS INC | 760273102 | 2,428,335 | $25.7M | 0.99% |
| 32 | COGENT BIOSCIENCES INC | COGT | 2,053,333 | $24.3M | 0.93% |
| 33 | CHARLES RIV LABS INTL INC | 159864107 | 114,351 | $24.0M | 0.92% |
| 34 | ZIMMER BIOMET HOLDINGS INC | ZBH | 151,372 | $22.0M | 0.85% |
| 35 | IQVIA HLDGS INC | IQV | 94,409 | $21.2M | 0.81% |
| 36 | BOSTON SCIENTIFIC CORP | BSX | 391,178 | $21.2M | 0.81% |
| 37 | HUMANA INC | HUM | 46,310 | $20.7M | 0.79% |
| 38 | VERVE THERAPEUTICS INC | 92539P101 | 1,061,960 | $19.9M | 0.76% |
| 39 | ENTRADA THERAPEUTICS INC | TRDA | 1,311,572 | $19.9M | 0.76% |
| 40 | PRIME MEDICINE INC | PRME | 1,324,350 | $19.4M | 0.74% |
| 41 | CABALETTA BIO INC | CABA | 1,370,299 | $17.7M | 0.68% |
| 42 | SHATTUCK LABS INC | STTK | 5,619,914 | $17.5M | 0.67% |
| 43 | 89BIO INC | 282559103 | 761,955 | $14.4M | 0.55% |
| 44 | GRITSTONE BIO INC | 39868T105 | 6,860,226 | $13.4M | 0.51% |
| 45 | ANNEXON INC | ANNX | 3,503,190 | $12.3M | 0.47% |
| 46 | ABSCI CORPORATION | ABSI | 8,031,094 | $12.2M | 0.47% |
| 47 | ALLAKOS INC | 01671P100 | 2,283,594 | $10.0M | 0.38% |
| 48 | STEREOTAXIS INC | STXS | 6,373,898 | $9.8M | 0.37% |
| 49 | ATARA BIOTHERAPEUTICS INC | ATRA | 6,048,123 | $9.7M | 0.37% |
| 50 | ALX ONCOLOGY HLDGS INC | ALXO | 1,283,289 | $9.6M | 0.37% |
| 51 | MEDAVAIL HOLDINGS INC | 58406B103 | 34,604,516 | $8.5M | 0.33% |
| 52 | RAPT THERAPEUTICS INC | 75382E109 | 431,919 | $8.1M | 0.31% |
| 53 | ACELYRIN INC | 00445A100 | 364,493 | $7.6M | 0.29% |
| 54 | STEVANATO GROUP S P A | STVN | 218,169 | $7.1M | 0.27% |
| 55 | ALLOVIR INC | 019818103 | 1,907,969 | $6.5M | 0.25% |
| 56 | EVOLENT HEALTH INC | EVH | 213,432 | $6.5M | 0.25% |
| 57 | MERSANA THERAPEUTICS INC | 59045L106 | 1,698,626 | $5.6M | 0.21% |
| 58 | GRIFOLS S A | GIKLY | 600,684 | $5.5M | 0.21% |
| 59 | NUVATION BIO INC | NUVB | 3,031,009 | $5.5M | 0.21% |
| 60 | SOMALOGIC INC | 83444K105 | 1,870,839 | $4.3M | 0.17% |
| 61 | LAVA THERAPEUTICS NV | N51517105 | 2,074,372 | $4.2M | 0.16% |
| 62 | SCIENCE 37 HOLDINGS INC | 808644108 | 19,808,234 | $4.2M | 0.16% |
| 63 | HOOKIPA PHARMA INC | HOOK | 3,288,469 | $2.9M | 0.11% |
| 64 | XERIS BIOPHARMA HOLDINGS INC | XERS | 1,046,587 | $2.7M | 0.11% |
| 65 | INVITAE CORP | 46185L103 | 2,280,403 | $2.6M | 0.10% |
| 66 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 2,912,228 | $2.4M | 0.09% |
| 67 | ACHILLES THERAPEUTICS PLC | 00449L102 | 1,608,089 | $1.5M | 0.06% |
| 68 | INVIVYD INC | IVVD | 1,440,725 | $1.5M | 0.06% |
| 69 | ALPHA TEKNOVA INC | TKNO | 308,852 | $824,635 | 0.03% |
| 70 | SONENDO INC | SONX | 498,131 | $677,458 | 0.03% |
| 71 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 715,607 | $661,936 | 0.03% |
| 72 | ATRECA INC | 04965G109 | 442,653 | $433,800 | 0.02% |